Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M800379-JLR200 on November 22, 2008

Papers In Press, published online ahead of print April 1, 2009
J. Lipid Res., doi:10.1194/jlr.M800379-JLR200
This Article
Free via Author's Choice: AC
Right arrow AC Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrowAC All Versions of this Article:
M800379-JLR200v1
50/4/630    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chakravarthy, M. V.
Right arrow Articles by Semenkovich, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chakravarthy, M. V.
Right arrow Articles by Semenkovich, C. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 50, 630-640, April 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology

Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation*,boxs

Manu V. Chakravarthy*, Yimin Zhu*, Li Yin*, Trey Coleman*, Kirk L. Pappan{dagger}, Connie A. Marshall{dagger}, Michael L. McDaniel{dagger} and Clay F. Semenkovich1,*,§

* Department of Medicine, Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine in St. Louis, MO 63110
{dagger} Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, MO 63110
§ Department of Cell Biology & Physiology, Washington University School of Medicine in St. Louis, MO 63110

* This work was supported by the American Diabetes Association (Junior Faculty Award 1-07-JF-12 to MVC and a Mentor-Based Postdoctoral Fellowship Award), National Institutes of Health grants DK076729 and P50 HL083762, and the Clinical Nutrition Research Unit (DK56341) and Diabetes Research and Training Center (DK20579).

boxsThe online version of this article (available at http://www.jlr.org) contains supplementary data in the form of two tables and one figure.

Published, JLR Papers in Press, November 22, 2008.

1 To whom correspondence should be addressed. e-mail: csemenko{at}wustl.edu

Obesity promotes insulin resistance and chronic inflammation. Disrupting any of several distinct steps in lipid synthesis decreases adiposity, but it is unclear if this approach coordinately corrects the environment that propagates metabolic disease. We tested the hypothesis that inactivation of FAS in the hypothalamus prevents diet-induced obesity and systemic inflammation. Ten weeks of high-fat feeding to mice with inactivation of FAS (FASKO) limited to the hypothalamus and pancreatic β cells protected them from diet-induced obesity. Though high-fat fed FASKO mice had no β-cell phenotype, they were hypophagic and hypermetabolic, and they had increased insulin sensitivity at the liver but not the periphery as demonstrated by hyperinsulinemic-euglycemic clamps, and biochemically by increased phosphorylated Akt, glycogen synthase kinase-3beta, and FOXO1 compared with wild-type mice. High-fat fed FASKO mice had decreased excretion of urinary isoprostanes, suggesting less oxidative stress and blunted tumor necrosis factor alpha (TNF{alpha}) and interleukin-6 (IL-6) responses to endotoxin, suggesting less systemic inflammation. Pair-feeding studies demonstrated that these beneficial effects were dependent on central FAS disruption and not merely a consequence of decreased adiposity. Thus, inducing central FAS deficiency may be a valuable integrative strategy for treating several components of the metabolic syndrome, in part by correcting hepatic insulin resistance and suppressing inflammation.

Supplementary key words metabolic syndrome • insulin resistance • type 2 diabetes mellitus

Abbreviations: HFD, high-fat diet; IL-6, interleukin-6; FASKO, fatty acid synthase knockout; Ppar, peroxisome-proliferator-activated receptor; TNF{alpha}, tumor necrosis factor alpha


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Song, M. Wohltmann, S. Bao, J. H. Ladenson, C. F. Semenkovich, and J. Turk
Mice deficient in Group VIB phospholipase A2 (iPLA2{gamma}) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet
Am J Physiol Endocrinol Metab, June 1, 2010; 298(6): E1097 - E1114.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement